EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Steroid‐Modulated Transcription Synergistically Forms DNA Double‐Strand Breaks With Topoisomerase II Inhibitor

Ying Zhao, Tetsuro Hisayoshi, Doudou Zhang, Saaya Suzuki, Takashi Watanabe, Atsuo Kobayashi, Qianqian Guo, Yukihide Momozawa iD, Takashi Shimokawa iD, Shunsuke Kato, Yoshio Miki, Shigeaki Sunada iD

Cancer Science · 2025

DOI: 10.1111/cas.70081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Ying Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan. Hauptthemen laut MEDLINE: DNA Breaks, Double-Stranded, Topoisomerase II Inhibitors, Etoposide, Medroxyprogesterone Acetate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MEXT Leading Initiative for Excellent Young Researchers, Japan Society for the Promotion of Science, Research Support Project for Life Science and Drug Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The synergistic effects of drug combinations have emerged as a promising approach for achieving efficient cancer treatment. Through our exploration of drug combinations, we found that medroxyprogesterone acetate (MPA), a steroid, induced a synergistic antitumor effect in combination with the topoisomerase II inhibitor etoposide (ETP). In this study, we investigated the mechanisms underlying this synergistic effect for potential clinical applications. To elucidate the relevant mechanisms, we performed a cell viability assay, cell cycle analysis, DNA repair assays, detection of DNA double‐strand breaks (DSBs) and the nuclear localization of topoisomerase II (Top2), and genome‐wide detection of DSBs. MPA synergistically increased ETP‐induced DSBs, resulting in cell cycle arrest in the G2/M phase. Interestingly, this effect was not due to the inhibition of DSB repair but to a specific increase in the Top2‐DNA covalent complex formed by ETP. A genome‐wide search for DSB locations revealed that DSB formation was promoted near promoter regions, suggesting the involvement of MPA transcriptional modulation in this mechanism. We also found that various steroids promoted DSB formation when combined with ETP, strongly supporting our synergistic model. Therefore, this synergistic effect is based on an innovative mechanism that differs from conventional strategies targeting the DNA damage response and is expected to contribute toward novel therapeutic options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Breaks, Double-StrandedTopoisomerase II InhibitorsEtoposideMedroxyprogesterone AcetateTranscription, GeneticHumansDNA Topoisomerases, Type IIDrug SynergismCell Line, TumorDNA RepairCell Survival

Stichwörter der Autor:innen

combination drug therapydouble‐stranded DNA breaksteroidstopoisomerase II inhibitorstranscriptional activation

Substanzen

Topoisomerase II InhibitorsEtoposideDNA Topoisomerases, Type IIMedroxyprogesterone Acetate

Autor:innen und Institutionen

  • Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Clinical Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
  • Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
  • Research and Development Center for Precision Medicine, University of Tsukuba, Ibaraki, Japan.

ORCID-Profile: Yukihide Momozawa, Takashi Shimokawa, Shigeaki Sunada

Förderung

  • MEXT Leading Initiative for Excellent Young Researchers
  • Japan Society for the Promotion of Science
  • Research Support Project for Life Science and Drug Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED

Zitieren

APA

Zhao, Y., Hisayoshi, T., Zhang, D., Suzuki, S., Watanabe, T., Kobayashi, A., Guo, Q., Momozawa, Y., Shimokawa, T., Kato, S., Miki, Y., & Sunada, S. (2025). Steroid‐Modulated Transcription Synergistically Forms DNA Double‐Strand Breaks With Topoisomerase II Inhibitor. Cancer Science. https://doi.org/10.1111/cas.70081

Vancouver

Zhao Y, Hisayoshi T, Zhang D, Suzuki S, Watanabe T, Kobayashi A, et al. Steroid‐Modulated Transcription Synergistically Forms DNA Double‐Strand Breaks With Topoisomerase II Inhibitor. Cancer Science. 2025. doi:10.1111/cas.70081

BibTeX
@article{Zhao2025,
  author = {Zhao, Ying and Hisayoshi, Tetsuro and Zhang, Doudou and Suzuki, Saaya and Watanabe, Takashi and Kobayashi, Atsuo and Guo, Qianqian and Momozawa, Yukihide and Shimokawa, Takashi and Kato, Shunsuke and Miki, Yoshio and Sunada, Shigeaki},
  title = {Steroid‐Modulated Transcription Synergistically Forms DNA Double‐Strand Breaks With Topoisomerase II Inhibitor},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.70081}
}
Kostenlos starten →